Preferred Label : indacaterol-glycopyrronium combination;

MeSH note : a dual bronchodilator consisting of the long-acting beta2-agonist indacaterol and the long-acting muscarinic antagonist glycopyrronium (NVA237) for treatment of patients with moderate to severe chronic obstructive pulmonary disease;

CISMeF synonym : QVA149;

Is substance : O;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3481441/fr/ultibro-breezhaler-indacaterol/bromure-de-glycopyrronium-bronchopneumopathie-chronique-obstructive-bpco
2024
false
false
false
France
indacaterol
insurance, health, reimbursement
treatment outcome
drug combinations
indacaterol-glycopyrronium combination
adult
administration, inhalation
evaluation of the transparency committee
Glycopyrronium
pulmonary disease, chronic obstructive

---
https://minerva-ebp.be/fr/article/1054
2015
false
false
false
minerva-ebm.be
Belgium
French
critical appraisal or critical reading
pulmonary disease, chronic obstructive
drug therapy, combination
treatment outcome
indacaterol
glycopyrrolate
muscarinic antagonists
bronchodilator agents
indacaterol-glycopyrronium combination
Tiotropium Bromide
indans
quinolones
glycopyrrolate

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1010
2015
false
false
false
false
Canada
French
drug combinations
administration, inhalation
indacaterol-glycopyrronium combination
indacaterol
critical appraisal or critical reading
glycopyrrolate
cholinergic antagonists
adrenergic beta-2 receptor agonists
pulmonary disease, chronic obstructive
bronchodilator agents
treatment outcome
multicenter studies as topic
COPD exacerbation
disease exacerbation
indacaterol and glycopyrronium bromide
quality of life
disease progression
indans
quinolones
glycopyrrolate

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.